Sciety user Merve Tepe ๐ท๐๐บ๐ฆ๐๏ธโฎ๏ธ
      
        Sciety handle @mervetepePhD
      
    
  - Lists (1)
- Following (10)
- 
    ASAPbio crowd reviewWe promote the productive use of preprints for research dissemination and transparent peer review and feedback on all research outputs.  
- 
    Rapid Reviews Infectious DiseasesRR\ID (Rapid Reviews\Infectious Diseases) is an open-access overlay journal that accelerates peer review of important infectious disease-related research preprints.  
- 
    eLifeeLife reviews preprints in the life sciences and medicine.  
- 
    preLightspreLights is a community initiative supported by The Company of Biologists.  
- 
    PeerRefPeerRef is a journal-independent open peer review platform for all research.  
- 
    GigaScienceGigaScience is an open access, open data, open peer-review journal focusing on โbig dataโ research from the life and biomedical sciences.  
- 
    NCRCThe 2019 Novel Coronavirus Research Compendium (NCRC) is a centralized, publicly available resource that rapidly curates and reviews the emerging scientific evidence about SARS-CoV-2 and COVID-19. Our goal is to provide accurate, relevant information for global public health action by clinicians, public health practitioners, and policy makers.  
- 
    PeerJPeerJ is an open access publisher of 7 peer-reviewed journals, and an editorial community of over 2000 Academic Editors and Advisors, and tens of thousands of authors and reviewers.  
- 
    ScreenITThe Automated Screening Working Groups is a group of software engineers and biologists passionate about improving scientific manuscripts on a large scale. Our members have created tools that check for common problems in scientific manuscripts, including information needed to improve transparency and reproducibility. We have combined our tools into a single pipeline, called ScreenIT. We're currently using our tools to screen COVID preprints.  
- 
    Review CommonsReview Commons is a platform for high-quality journal-independent peer-review in the life sciences.